Efficacy of Savolitinib vs Sunitinib in Patients With MET-Driven Papillary Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Efficacy of Savolitinib vs Sunitinib in Patients With MET-Driven Papillary Renal Cell Carcinoma

Published:2020-08-01 Issue:8 Volume:6 Page:1247
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Choueiri Toni K.¹,Heng Daniel Y. C.²,Lee Jae Lyun³,Cancel Mathilde⁴,Verheijen Remy B.⁵,Mellemgaard Anders⁵,Ottesen Lone H.⁵,Frigault Melanie M.⁶,L’Hernault Anne⁵,Szijgyarto Zsolt⁵,Signoretti Sabina⁷,Albiges Laurence⁸⁹

Affiliation:

1. Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts

2. Department of Medical Oncology, Tom Baker Cancer Center, University of Calgary, Calgary, Canada

3. Asan Medical Center and University of Ulsan College of Medicine, Seoul, South Korea

4. CHU Bretonneau Centre, Tours University, France

5. Oncology R&D, AstraZeneca, Cambridge, United Kingdom

6. Oncology R&D, AstraZeneca, Boston, Massachusetts

7. Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts

8. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

9. Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2766797/jamaoncology_choueiri_2020_oi_200031_1597168372.33355.pdf

Reference40 articles.

1. Cancer statistics, 2020.;Siegel;CA Cancer J Clin,2020

2. The epidemiology of renal cell carcinoma.;Ljungberg;Eur Urol,2011

3. Renal cell carcinoma.;Hsieh;Nat Rev Dis Primers,2017

4. Systemic therapy for non-clear cell renal cell carcinomas: a systematic review and meta-analysis.;Vera-Badillo;Eur Urol,2015

5. Non-clear cell renal cell carcinomas: from shadow to light.;Albiges;J Clin Oncol,2018

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Explainable machine learning prediction of edema adverse events in patients treated with tepotinib;Clinical and Translational Science;2024-09

2. Drug-induced liver injury associated with savolitinib: a novel case report and causality assessment;BMC Pulmonary Medicine;2024-08-09

3. Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Annals of Oncology;2024-08

4. Effective strategies to enhance the diagnosis and treatment of RCC: The application of biocompatible materials;Materials Today Bio;2024-08

5. PD-L1 expression and its prognostic value in metastatic papillary renal cell carcinoma: Results from a GETUG multicenter retrospective cohort;European Journal of Cancer;2024-07